Ignite Creation Date:
2025-12-24 @ 4:27 PM
Ignite Modification Date:
2026-04-22 @ 1:01 PM
Study NCT ID:
NCT01724866
Status:
COMPLETED
Last Update Posted:
2022-04-15
First Post:
2012-10-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SPI-GCF-12-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None